IBX.AX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 kov. 2024 @ 06:50):

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy...

Stats
Dzisiejszy wolumen	13 188.00
Średni wolumen	37 506.00
Kapitalizacja rynkowa	2.42M
EPS	$0 ( 2024-04-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.170
ATR14	$0.00700 (9.46%)

Wolumen Korelacja

Długi: -0.24 (neutral)

Krótki: -0.39 (neutral)

Signal:(31.809) Neutral

Imagion Biosystems Ltd Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Imagion Biosystems Ltd Korelacja - Waluta/Towar

-0.86
( strong negative )

-0.45
( neutral )

0.00
( neutral )

-0.52
( weak negative )

0.83
( strong )

Imagion Biosystems Ltd Finanse

Annual	2023
Przychody:	$1.65M
Zysk brutto:	$-3.61M (-219.14 %)
EPS:	$-0.400

FY	2023
Przychody:	$1.65M
Zysk brutto:	$-3.61M (-219.14 %)
EPS:	$-0.400

FY	2022
Przychody:	$473 429
Zysk brutto:	$-3.14M (-663.76 %)
EPS:	$-0.350

FY	2021
Przychody:	$232 865
Zysk brutto:	$232 865 (100.00 %)
EPS:	$-0.00806

Financial Reports:

No articles found.

Imagion Biosystems Ltd

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.